TRAVERE THERAPEUTICS INC. - COMMON STOCK
17.44
26-八月-25 13:45:00
15 分钟延时
股票
+0.21
+1.22%
今日范围
17.13 - 17.54
ISIN
N/A
来源
NASDAQ
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 3月 2022 14:00:00 条件 Nasdaq GlobeNewswire
-
Travere Prices Upsized $275 Million Convertible Senior Notes Offering
08 3月 2022 18:00:26 条件 Nasdaq GlobeNewswire
-
Travere Announces Proposed Convertible Senior Notes Offering
08 3月 2022 04:00:01 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the Barclays Global Healthcare Conference
03 3月 2022 13:30:00 条件 Nasdaq GlobeNewswire
-
28 2月 2022 05:00:02 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
24 2月 2022 13:01:01 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 2月 2022 14:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results
10 2月 2022 13:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
09 2月 2022 13:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 1月 2022 14:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Provides Corporate Update and 2022 Outlook
10 1月 2022 04:00:02 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Appoints Jula Inrig, M.D., as Chief Medical Officer
04 1月 2022 13:30:00 条件 Nasdaq GlobeNewswire
-
15 12月 2021 04:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 12月 2021 13:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at Upcoming Investor Conferences
11 11月 2021 13:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present Abstracts at American Society of Nephrology Kidney Week 2021
02 11月 2021 13:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Third Quarter 2021 Financial Results and Organizational Progress
28 10月 2021 13:01:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Report Third Quarter 2021 Financial Results
14 10月 2021 13:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 10月 2021 14:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Announces Transition of Chief Medical Officer
12 10月 2021 14:00:00 条件 Nasdaq GlobeNewswire